Dabuzalgron (Ro 115-1240) is an orally active and selective alpha-1A adrenergic receptor agonist for the treatment of urinary incontinence. Dabuzalgron protects against Doxorubicin-induced cardiotoxicity by preserving mitochondrial function[1].
Molecular Weight:
317.79
Purity:
98.72
CAS Number:
[219311-44-1]
Formula:
C12H16ClN3O3S
Target:
Adrenergic Receptor,Apoptosis
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted